Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | NPC1 | O15118 | 6/20 | 0.62 |
| ▸ | RAB9A | P51151 | 6/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.47 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.42 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL942764 | 0.84 | ALDH1A1 (0.65) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL3884828 | 0.82 | SMN1; SMN2 (0.58) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL1853028 | 0.81 | ALDH1A1 (0.62) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL1849445 | 0.81 | RAB9A (0.62) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL28658650 | 0.81 | NPC1 (0.62) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL29089761 | 0.81 | ALDH1A1 (0.62) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL1847594 | 0.81 | RAB9A (0.61) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL7169890 | 0.81 | ALDH1A1 (0.57) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL321553 | 0.78 | ALOX15 (0.48) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL3885389 | 0.78 | MAPT (0.57) | ALDH1A1NPC1RAB9ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796800-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2017-10-24 | — | — | US | claimed |
| US-20160108153-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2016-04-21 | — | — | US | claimed |
| US-9249244-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2016-02-02 | — | — | US | claimed |
| EP-2619233-A1 | PROCESS FOR PRODUCING POLYDIENES | Bridgestone Corporation (JP) | 2013-07-31 | — | — | EP | claimed |
| WO-2012040026-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2012-03-29 | — | — | WO | claimed |
| CN-115537853-B | Direct electrochemical synthesis method of triarylamine compound | 浙江工业大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-117758282-A | Electrocatalytic preparation method of (indolizine-3-yl) -ethanedione derivative | 上海陶术生物科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-116272256-A | Method and device for collecting tobacco fragrance in redried tobacco tail gas | 云南烟叶复烤有限责任公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-115537853-A | Direct electrochemical synthesis method of triarylamine compound | 浙江工业大学 | 2022-12-30 | — | — | CN | disclosed |
| CN-113582989-B | Preparation method of cyanized or thiocyanized indolizine and derivatives thereof | 广东药科大学 | 2022-07-08 | — | — | CN | disclosed |
| CN-113582989-A | Preparation method of cyanized or thiocyanized indolizine and derivatives thereof | 广东药科大学 | 2021-11-02 | — | — | CN | disclosed |
| CN-111138432-B | Method for preparing pyrrole [2,1,5-cd ] indolizine ring derivative through metal-free photocatalysis | 广东药科大学 | 2021-03-19 | — | — | CN | disclosed |
| EP-1888063-B1 | ANTIFUNGAL AGENTS | F2G LTD (GB) | 2009-01-14 | — | — | EP | disclosed |
| US-20080161302-A1 | N-(2-Methoxy-phenyl)-2-oxo-2-(2-phenyl-indolizin-3-yl)-acetamide; antifungal agents; inhibiting Aspergillus | F2G LTD. (GB) | 2008-07-03 | — | — | US | disclosed |
| EP-1888063-A1 | ANTIFUNGAL AGENTS | F2G Ltd. (GB) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006123145-A1 | ANTIFUNGAL AGENTS | F2G LTD (GB) | 2006-11-23 | — | — | WO | disclosed |
| EP-0480204-B1 | Imidazole derivatives, potent and selective antagonists of angiotensin II receptor | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-03-20 | — | — | EP | disclosed |
| US-5215994-A | Treating or preventing hypertension or heart failure | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-01 | — | — | US | disclosed |
| US-5210092-A | Hypotensive agents | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-05-11 | — | — | US | disclosed |
| EP-0480204-A1 | Imidazole derivatives, potent and selective antagonists of angiotensin II receptor | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161302-A1 | N-(2-Methoxy-phenyl)-2-oxo-2-(2-phenyl-indolizin-3-yl)-acetamide; antifungal agents; inhibiting Aspergillus | NAT1, CYP1A2, CYP51A1 | ALDH1A1 510/4885NPC1 1899/4885RAB9A 3669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.